Submitted by Anonymous (not verified) on 8 October 2024 - 15:25
Human medicines European public assessment report (EPAR): Oxbryta, Voxelotor, Date of authorisation: 14/02/2022, Revision: 5, Status: Suspended
Source:
Human medicines European public assessment report (EPAR): Oxbryta, Voxelotor, Date of authorisation: 14/02/2022, Revision: 5, Status: Suspended